SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company: Larimar Therapeutics, Inc.
Filed: February 13, 2020
Accession Number: 0001013594-20-000130

View Document ↗ View on SEC.gov ↗